Research project
101016964 REAP
Revealing drug tolerant persister cells in cancer using contrast enhanced optical coherence and photoacoustic tomography (REAP)
date_range
Duration: from 01 January 2021 to 31 December 2024
(48 months)
With a Private character. It has been granted under a regime of Competitive.
In collaboration with other entities.
Call:
795
H2020-ICT-2020-2
Program:
Industrial Leadership
Subprogram:
Leadership in enabling and industrial technologies - LEIT: Information and communication technologies
